OSCR
Income statement / Annual
Last year (2023), Oscar Health, Inc.'s total revenue was $5.86 B,
an increase of 42.11% from the previous year.
In 2023, Oscar Health, Inc.'s net income was -$270.73 M.
See Oscar Health, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$5.86 B
|
$4.13 B
|
$1.92 B
|
$589.64 M
|
$553.78 M
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$5.86 B |
$4.13 B |
$1.92 B |
$589.64 M |
$553.78 M |
| Gross Profit Ratio |
1 |
1 |
1 |
1 |
1 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$339.72 M
|
$309.78 M
|
$265.08 M
|
$166.66 M
|
$110.68 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$339.72 M
|
$309.78 M
|
$265.08 M
|
$166.66 M
|
$110.68 M
|
| Other Expenses |
$5.76 B |
$4.24 B |
-$2.76 B |
-$1.16 B |
-$924.93 M |
| Operating Expenses |
$6.10 B |
$4.55 B |
-$2.50 B |
-$996.51 M |
-$814.24 M |
| Cost And Expenses |
$6.10 B |
$4.74 B |
$2.49 B |
$995.42 M |
$813.17 M |
| Interest Income |
$0.00 |
$31.31 M |
$10.25 M |
$8.01 M |
$11.12 M |
| Interest Expense |
$24.60 M |
$22.62 M |
$4.72 M |
$3.51 M |
$0.00 |
| Depreciation &
Amortization |
$30.69 M
|
$15.28 M
|
$14.61 M
|
$11.30 M
|
$6.90 M
|
| EBITDA |
-$212.00 M
|
-$572.17 M
|
-$551.26 M
|
-$390.97 M
|
-$252.49 M
|
| EBITDA Ratio |
-0.04 |
-0.14 |
-0.29 |
-0.67 |
-0.46 |
| Operating Income Ratio
|
-0.04
|
-0.14
|
-0.3
|
-0.69
|
-0.47
|
| Total Other
Income/Expenses Net |
-$31.69 M
|
-$20.21 M
|
-$26.10 M
|
-$3.51 M
|
$0.00
|
| Income Before Tax |
-$267.30 M |
-$610.08 M |
-$570.58 M |
-$405.78 M |
-$259.39 M |
| Income Before Tax Ratio
|
-0.05
|
-0.15
|
-0.3
|
-0.69
|
-0.47
|
| Income Tax Expense |
$3.29 M |
-$523,000.00 |
$846,000.00 |
$1.05 M |
$1.79 M |
| Net Income |
-$270.73 M |
-$609.55 M |
-$571.43 M |
-$406.83 M |
-$261.18 M |
| Net Income Ratio |
-0.05 |
-0.15 |
-0.3 |
-0.69 |
-0.47 |
| EPS |
-1.22 |
-2.87 |
-3.19 |
-1.7 |
-1.09 |
| EPS Diluted |
-1.22 |
-2.87 |
-3.19 |
-1.7 |
-1.09 |
| Weighted Average Shares
Out |
$221.66 M
|
$212.47 M
|
$178.97 M
|
$239.31 M
|
$239.31 M
|
| Weighted Average Shares
Out Diluted |
$221.66 M
|
$212.47 M
|
$178.97 M
|
$239.31 M
|
$239.31 M
|
| Link |
|
|
|
|
|
